Healthcare Providers Pour $3.7 Billion Into AI as Focus Shifts Beyond Documentation to Clinical Decision Support
New spending data reveals clinical copilots and front-office automation are growing five times faster than ambient scribing, with startups gaining ground against legacy EHR vendors.

Healthcare organizations are dramatically expanding their artificial intelligence investments, with total spending reaching $3.7 billion—more than double the previous year—according to a new Menlo Partners report surveying over 550 U.S. healthcare and life sciences executives. The surge reflects a strategic pivot beyond ambient documentation toward clinical copilots and front-office automation that address broader operational challenges.
Clinical Copilots and Patient Engagement Lead Growth
The most striking finding is the approximately five-fold growth in two emerging categories: clinical copilots, which reached $550 million in investment, and patient engagement and front-office AI, which grew to $450 million. This explosive expansion contrasts sharply with ambient scribing and coding/billing solutions, which grew less than two times year-over-year despite their larger installed base.
OpenEvidence has emerged as the most popular choice for clinical copilots among surveyed providers, according to the report. The shift toward clinical decision support tools reflects provider appetite for AI that extends beyond documentation to actively assist with diagnostic and treatment decisions.
Provider organizations account for 77% of total healthcare AI spending, underscoring their role as the primary drivers of adoption. Notably, only 16% of providers prefer keeping patient navigation within their electronic health record system, compared to over two-thirds for coding, billing, and chart review functions—a preference pattern that creates significant opportunities for standalone AI solutions in patient-facing workflows.
Legacy Vendors Consolidate Ambient Scribing Market
While clinical copilots and front-office tools surge, the ambient scribing market is consolidating around established health IT vendors. Microsoft Dragon Copilot and Epic's Art captured 68% of new ambient scribing dollars in 2024, with legacy vendors now holding 46% overall market share. AI startups lost 13% market share in this category, forcing many to pivot toward adjacent clinical and administrative workflows.
The competitive dynamics suggest providers are increasingly comfortable consolidating ambient documentation with their existing EHR vendors while remaining open to startup solutions for emerging use cases like prior authorization, clinical decision support, and patient engagement.
Regulatory Innovation Enables New Use Cases
The report highlights several developments expanding AI's clinical role. Utah's regulatory sandbox enabled Doctronic to process prescription renewals for 191 medications, demonstrating how regulatory flexibility can accelerate AI deployment in direct patient care. Meanwhile, ARPA-H is investing $62.7 million in 24/7 AI agents for heart failure patient monitoring, pointing toward continuous remote care management applications.
Integration partnerships are also advancing, with Abridge partnering with Availity for real-time prior authorization and Heidi partnering with R1 to integrate payer prior authorization policies directly into clinical encounters. These collaborations address administrative burden at the point of care rather than as a separate workflow.
Looking Ahead
The five-fold growth in clinical copilots and front-office automation represents a maturation of healthcare AI beyond its initial documentation-focused applications. As providers diversify their AI portfolios, the competitive landscape is bifurcating: established vendors are consolidating commodity functions like ambient scribing, while startups are capturing growth in higher-value clinical decision support and patient engagement workflows. The challenge ahead will be ensuring interoperability and data continuity across increasingly fragmented vendor ecosystems as AI touches more aspects of care delivery.
Sources
Companies in this article
Follow Health AI Central
Keep up with health AI where you already read
On LinkedIn
The day’s strongest health AI stories in your feed, one or two each weekday.
On Google
Choose Health AI Central as a preferred source, and Google is more likely to show our reporting in Top Stories.
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.